DICE Therapeutics
chee ase | DICE Therapeutics
Company
Deck Type
Deck date
March 2023
Slide
4 of 14
Related slides by other companies
BenevolentAI
Results
March 2023
ben indicative data from phase caveats phase was not powered to meaningfully assess only patients dosed with active per group maximum duration of dosing days score changes typically measured at days mean change from affected in treated areas day bid | BenevolentAI
OmniAb
Investor Presentation
August 2023
growth of partner programs | OmniAb
GH Research
Investor Presentation
March 2023
design of phase trial in healthy volunteers | GH Research
MindMed
Investor Presentation
November 2024
phase trial schematic emerge study study week gee toe a study single dose of for | MindMed
Other recent decks by DICE Therapeutics
See all presentations (4 decks)
Investor Presentation
March 2023
Investor Presentation
March 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io